Armata Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
1,011
across all filing types
Latest filing
2025-11-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
ARMP
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2025-11-12 | English | |
| 8-K | 2025-11-12 | English | |
| FORM 8-K | 2025-10-22 | English | |
| FORM 8-K | 2025-09-10 | English | |
| Regulatory Filings 2025 | 2025-08-25 | English | |
| Regulatory Filings 2025 | 2025-08-20 | English |
Browse filings by year
24 years- 2026 13 filings
- 2025 39 filings
- 2024 36 filings
- 2023 44 filings
- 2022 40 filings
- 2021 45 filings
- 2020 51 filings
- 2019 59 filings
- 2018 42 filings
- 2017 60 filings
- 2016 69 filings
- 2015 70 filings
- 2014 66 filings
- 2013 5 filings
- 2011 1 filing
- 2010 36 filings
- 2009 51 filings
- 2008 39 filings
- 2007 58 filings
- 2006 46 filings
- 2005 64 filings
- 2004 39 filings
- 2003 34 filings
- 2002 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 10146909 | 10-Q | 2025-11-12 | English | ||
| 10146916 | 8-K | 2025-11-12 | English | ||
| 10146913 | FORM 8-K | 2025-10-22 | English | ||
| 10146921 | FORM 8-K | 2025-09-10 | English | ||
| 10146922 | Regulatory Filings 2025 | 2025-08-25 | English | ||
| 10146923 | Regulatory Filings 2025 | 2025-08-20 | English | ||
| 10146926 | Regulatory Filings 2025 | 2025-08-15 | English | ||
| 10146924 | FORM S-8 | 2025-08-13 | English | ||
| 10146925 | FORM S-3 | 2025-08-13 | English | ||
| 10146927 | Major Shareholding Notification 2025 | 2025-08-12 | English | ||
| 10146931 | 10-Q | 2025-08-12 | English | ||
| 10146933 | 8-K | 2025-08-12 | English | ||
| 10146932 | OWNERSHIP DOCUMENT | 2025-07-14 | English | ||
| 10146934 | FORM 8-K | 2025-06-13 | English | ||
| 10146937 | FORM 8-K | 2025-05-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Armata Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34152/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34152 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34152 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34152 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34152}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Armata Pharmaceuticals, Inc. (id: 34152)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.